1-10 of 10
Yi Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study

Zhiyuan Bo, Bo Chen, Zhengxiao Zhao, Qikuan He, Yicheng Mao, Yunjun Yang, Fei Yao, Yi Yang, Ziyan Chen, Jinhuan Yang, Haitao Yu, Jun Ma, Lijun Wu, Kaiyu Chen, Luhui Wang, Mingxun Wang, Zhehao Shi, Xinfei Yao, Yulong Dong, Xintong Shi, Yunfeng Shan, Zhengping Yu, Yi Wang, Gang Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1730–1740.
https://doi.org/10.1158/1078-0432.CCR-22-2784
Published: 01 May 2023
View article titled, Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
Open the PDF for Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

Martin H. Voss, Arun A. Azad, Aaron R. Hansen, Jhanelle E. Gray, Sarah J. Welsh, Xuyang Song, Michael Kuziora, Lina Meinecke, Jorge Blando, Ikbel Achour, Yi Wang, Farzana L. Walcott, Sjoukje F. Oosting
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3032–3041.
https://doi.org/10.1158/1078-0432.CCR-21-4115
Published: 15 July 2022
View article titled, A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
Open the PDF for A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

Hong Luo, Jingwen Su, Ruixin Sun, Yansha Sun, Yi Wang, Yiwei Dong, Bizhi Shi, Hua Jiang, Zonghai Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5494–5505.
https://doi.org/10.1158/1078-0432.CCR-20-0777
Published: 15 October 2020
View article titled, Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Open the PDF for Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion in another window
Includes: Supplementary data
Journal Articles

Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer

Chelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, Uksha Saini, Kellie S. Rath, Timothy P. Cripe, Jianying Zhang, Karuppaiyah Selvendiran, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6479–6494.
https://doi.org/10.1158/1078-0432.CCR-14-0463
Published: 14 December 2014
View article titled, Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
Open the PDF for Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Lingmin Hu, Chen Wu, Xueying Zhao, Rebecca Heist, Li Su, Yang Zhao, Baohui Han, Songyu Cao, Minjie Chu, Juncheng Dai, Jing Dong, Yongqian Shu, Lin Xu, Yijiang Chen, Yi Wang, Feng Lu, Yue Jiang, Dianke Yu, Hongyan Chen, Wen Tan, Hongxia Ma, Jiaping Chen, Guangfu Jin, Tangchun Wu, Daru Lu, David C. Christiani, Dongxin Lin, Zhibin Hu, Hongbing Shen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5507–5514.
https://doi.org/10.1158/1078-0432.CCR-12-1202
Published: 30 September 2012
View article titled, Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
Open the PDF for Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma

Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Wenli Zhang, Yang Bi, Jiayi Huang, Yi Wang, Wei Jiang, Qing Luo, Qiong Shi, Bing-Qiang Zhang, Bo Liu, Xia Lei, Jinyong Luo, Xiaoji Luo, Eric R. Wagner, Stephanie H. Kim, Connie J. He, Yawen Hu, Jikun Shen, Qixin Zhou, Farbod Rastegar, Zhong-Liang Deng, Hue H. Luu, Tong-Chuan He, Rex C. Haydon
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2235–2245.
https://doi.org/10.1158/1078-0432.CCR-09-2499
Published: 14 April 2010
View article titled, Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma
Open the PDF for Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma in another window
Includes: Supplementary data
Journal Articles

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

Wen-Yi Wang, Chih-Wen Twu, Hsin-Hong Chen, Jian-Sheng Jan, Rong-San Jiang, Jeffrey Y.C. Chao, Kai-Li Liang, Kuan-Wen Chen, Ching-Te Wu, Jin-Ching Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (3): 1016–1024.
https://doi.org/10.1158/1078-0432.CCR-09-2796
Published: 01 February 2010
View article titled, Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
Open the PDF for Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Association of XPD Polymorphisms with Severe Toxicity in Non–Small Cell Lung Cancer Patients in a Chinese Population

Wenting Wu, Wei Zhang, Rong Qiao, Dan Chen, Huibo Wang, Yi Wang, Shuyu Zhang, Ge Gao, Aiqin Gu, Jie Shen, Ji Qian, Weiwei Fan, Li Jin, Baohui Han, Daru Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3889–3895.
https://doi.org/10.1158/1078-0432.CCR-08-2715
Published: 01 June 2009
View article titled, Association of <em>XPD</em> Polymorphisms with Severe Toxicity in Non–Small Cell Lung Cancer Patients in a Chinese Population
Open the PDF for Association of <em>XPD</em> Polymorphisms with Severe Toxicity in Non–Small Cell Lung Cancer Patients in a Chinese Population in another window
Includes: Supplementary data
Journal Articles

COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis

Ning-Fang Ma, Sze Hang Lau, Liang Hu, Dan Xie, Jun Wu, Jun Yang, Yi Wang, Meng-Chao Wu, Jackie Fung, Xueyan Bai, Chi-Hung Tzang, Li Fu, Mengsu Yang, Yan An Su, Xin-Yuan Guan
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5061–5068.
https://doi.org/10.1158/1078-0432.CCR-07-5082
Published: 12 August 2008
View article titled, COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis
Open the PDF for COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis in another window
Includes: Supplementary data
Journal Articles

Consistent Sequence Variation of Epstein-Barr Virus Nuclear Antigen 1 in Primary Tumor and Peripheral Blood Cells of Patients with Nasopharyngeal Carcinoma

Wen-Yi Wang, Yi-Chih Chien, Jian-Sheng Jan, Chun-Mei Chueh, Jin-Ching Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2586–2590.
Published: 01 August 2002
View article titled, Consistent Sequence Variation of Epstein-Barr Virus Nuclear Antigen 1 in Primary Tumor and Peripheral Blood Cells of Patients with Nasopharyngeal Carcinoma
Open the PDF for Consistent Sequence Variation of Epstein-Barr Virus Nuclear Antigen 1 in Primary Tumor and Peripheral Blood Cells of Patients with Nasopharyngeal Carcinoma in another window